Logo.jpg
Pharmaceutical Excipients Market To Reach USD 14.9 Billion By 2032 Report By DataHorizzon Research
07 févr. 2024 06h30 HE | DataHorizzon Research
Fort Collins, Colorado, Feb. 07, 2024 (GLOBE NEWSWIRE) -- The Pharmaceutical Excipients Market was valued at USD 8.3 Billion in 2022 and is anticipated to grow CAGR at 6.1% to reach USD 14.9 Billion...
84bd90f5-4a1f-42a8-8eb1-5cb062a0b6ac.png
Drug Delivery Devices Market Surges Towards USD 713.1 Billion by 2033 | Rising prevalence of Advanced Therapies and Chronic Diseases Drives Growth
07 févr. 2024 04h47 HE | Market.Us
New York, Feb. 07, 2024 (GLOBE NEWSWIRE) -- According to Market.us, the global Drug Delivery Devices Market size is forecasted to exceed USD 713.1 Billion by 2033, with a promising CAGR of 7.9% from...
logo.jpg
Processa Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule
06 févr. 2024 08h30 HE | Processa Pharmaceuticals, Inc.
HANOVER, MD, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next...
ONL logo.jpg
ONL Therapeutics to Present at 2024 BIO CEO & Investor Conference
06 févr. 2024 07h00 HE | ONL Therapeutics
ANN ARBOR, Mich., Feb. 06, 2024 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
84bd90f5-4a1f-42a8-8eb1-5cb062a0b6ac.png
Peptide Therapeutics Market Surges Towards USD 101.7 Billion by 2033 | Analyzing Growth in Therapeutic Innovations and Disease Management
05 févr. 2024 04h56 HE | Market.Us
New York, Feb. 05, 2024 (GLOBE NEWSWIRE) -- According to Market.us, the global Peptide Therapeutics Market size is forecasted to exceed USD 101.7 Billion by 2033, with a promising CAGR of 9.1% from...
PRISM MarketView Marks World Cancer Day
PRISM MarketView Marks World Cancer Day
01 févr. 2024 10h45 HE | PRISM MarketView
PRISM MarketView Marks World Cancer Day
84bd90f5-4a1f-42a8-8eb1-5cb062a0b6ac.png
Alzheimer’s Disease Therapeutics Market Value to Reach USD 30.8 Billion by 2033 | Driven by the Advancements in Neurological Research
30 janv. 2024 02h53 HE | Market.Us
New York, Jan. 30, 2024 (GLOBE NEWSWIRE) -- According to Market.us, the global Alzheimer’s Disease Therapeutics Market size is forecasted to exceed USD 30.8 Billion by 2033, with a promising CAGR of...
Transparency Market Research
Bone Marrow Aspirate Concentrates Market Size to Exceed USD 273.3 million By 2031, with a Robust CAGR of 5.3%| States Transparency Market Research, Inc.
29 janv. 2024 10h38 HE | Transparency Market Research
Wilmington, Delaware, United States, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global bone marrow aspirate concentrates market is estimated to flourish at a CAGR of...
Logo.jpg
First Patient Dosed with LIXTE’s LB-100 and GSK’s Immunotherapy Dostarlimab-gxly in Ovarian Clear Cell Carcinoma Trial
29 janv. 2024 08h30 HE | Lixte Biotechnology Holdings, Inc.
PASADENA, CA, Jan. 29, 2024 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT and LIXTW) (“LIXTE” or the “Company”), today announced the dosing of the first patient in a Phase...
Transparency Market Research
Pet Care Diabetes Drugs Market Size Expected to Exceed USD 1.1 billion by 2031, Driven by 6.4% CAGR - Transparency Market Research, Inc.
29 janv. 2024 05h57 HE | Transparency Market Research
Wilmington, Delaware, United States, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The pet care diabetes drugs industry was valued at US$ 621.8 million in 2022. By 2031, the...